Skip to content
10-Q

Quarterly Report

Surmodics, Inc.

0000950170-24-088249

← back to feed
Filed
Jul 31, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Jul 26, 2024 14.27M sh
Cash And Equivalents Q3 2024 · Jun 30, 2024 $24.3M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $41.42M
Current Liabilities Q3 2024 · Jun 30, 2024 $20.2M
Current Liabilities Q3 2024 · Sep 30, 2023 $23.95M
Total Liabilities Q3 2024 · Jun 30, 2024 $59.27M
Total Liabilities Q3 2024 · Sep 30, 2023 $65.82M
Current Assets Q3 2024 · Jun 30, 2024 $80.36M
Current Assets Q3 2024 · Sep 30, 2023 $86.69M
Total Assets Q3 2024 · Jun 30, 2024 $177.41M
Total Assets Q3 2024 · Sep 30, 2023 $185.73M
Shares Diluted Q3 2024 · Jun 30, 2023 14.07M sh
Shares Diluted Q3 2024 · Jun 30, 2023 14.02M sh
Capex Q3 2024 · Jun 30, 2023 $2.17M
Operating Cash Flow Q3 2024 · Jun 30, 2023 $9.26M
Stockholders Equity Q3 2024 · Jun 30, 2023 $112.41M
Stockholders Equity Q3 2024 · Mar 31, 2023 $102.55M
Stockholders Equity Q3 2024 · Sep 30, 2022 $108.39M
Eps Diluted Q3 2024 · Jun 30, 2023 $0.52
Eps Diluted Q3 2024 · Jun 30, 2023 −$0.59
Eps Basic Q3 2024 · Jun 30, 2023 $0.52
Eps Basic Q3 2024 · Jun 30, 2023 −$0.59
Sga Expense Q3 2024 · Jun 30, 2023 $12.87M
Sga Expense Q3 2024 · Jun 30, 2023 $39.08M
Net Income Q3 2024 · Jun 30, 2023 $7.35M
Net Income Q3 2024 · Jun 30, 2023 −$8.23M
Operating Income Q3 2024 · Jun 30, 2023 $21.41M
Operating Income Q3 2024 · Jun 30, 2023 $7.6M
Cost Of Revenue Q3 2024 · Jun 30, 2023 $6.92M
Cost Of Revenue Q3 2024 · Jun 30, 2023 $17.93M
Revenue Q3 2024 · Jun 30, 2023 $52.48M
Revenue Q3 2024 · Jun 30, 2023 $104.61M